Results per Page:
Transient transfection to make vaccines: cutting corners, or taking the express lane?
From The Kublin and Corey Labs, Vaccine and Infectious Disease Division
Turns out, HSV antivirals are (and aren’t) skin-deep
From The Zhu Lab, Vaccine and Infectious Disease Division
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
Oral Shedding: A Kaposi Sarcoma Mystery
From the Schiffer Lab, Vaccine and Infectious Disease Division and Clinical Research Division
Diaper deposits are decoding our earliest microbiomes
From the Kublin Lab, Vaccine and Infectious Disease Division
‘Action and progress link our globe’
HVTN’s Dr. Daniel Driffin focused on hope in remarks at White House World AIDS Day event
¿Necesito otra vacuna de refuerzo contra el SRAS-CoV-2?
Del Dr. Bo Zhang y laboratorios colaboradores, División de Vacunas y Enfermedades Infecciosas
How protective antibodies get in malaria’s way
Fred Hutch researchers’ structural insights help reveal weak spot in parasite’s mode of attack, could guide vaccine design
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Going straight to the source in defense against infant RSV
New anti-idiotype antibody a first step in possible strategy to build infant immunity during vulnerable window
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
Zeroing in on vaginal microbes that most increase HIV risk
Signature combination of BV bacteria and immune proteins associated with highest risk could help guide prevention
The curious case of ORF8: SARS-CoV-2 evolution is about more than just spike
From the Bedford Lab, Vaccine and Infectious Disease Division
One small step for mouse, one giant leap for representative mouse models
From the Lund Lab, Vaccine and Infectious Disease Division